Global Anti-Infective Agents for Pets Market Growth 2024-2030

Publication ID:

LPI11242123

Publication Date:

November 6, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Anti-infective agents for pets are medications used to prevent and treat infectious diseases in companion animals such as dogs, cats, birds, reptiles, and small mammals. These agents are similar to those used in humans and livestock but are tailored to the specific needs and sensitivities of pets.
The global Anti-Infective Agents for Pets market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淎nti-Infective Agents for Pets Industry Forecast鈥� looks at past sales and reviews total world Anti-Infective Agents for Pets sales in 2023, providing a comprehensive analysis by region and market sector of projected Anti-Infective Agents for Pets sales for 2024 through 2030. With Anti-Infective Agents for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infective Agents for Pets industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infective Agents for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infective Agents for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Anti-Infective Agents for Pets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infective Agents for Pets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infective Agents for Pets.
United States market for Anti-Infective Agents for Pets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Anti-Infective Agents for Pets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Anti-Infective Agents for Pets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Anti-Infective Agents for Pets players cover Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Agents for Pets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
External Use
Internal Use
Segmentation by Application:
Dogs
Cats
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Chanelle
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-Infective Agents for Pets market?
What factors are driving Anti-Infective Agents for Pets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infective Agents for Pets market opportunities vary by end market size?
How does Anti-Infective Agents for Pets break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Infective Agents for Pets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Anti-Infective Agents for Pets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Anti-Infective Agents for Pets by Country/Region, 2019, 2023 & 2030
2.2 Anti-Infective Agents for Pets Segment by Type
2.2.1 External Use
2.2.2 Internal Use
2.3 Anti-Infective Agents for Pets Sales by Type
2.3.1 Global Anti-Infective Agents for Pets Sales Market Share by Type (2019-2024)
2.3.2 Global Anti-Infective Agents for Pets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Anti-Infective Agents for Pets Sale Price by Type (2019-2024)
2.4 Anti-Infective Agents for Pets Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Other
2.5 Anti-Infective Agents for Pets Sales by Application
2.5.1 Global Anti-Infective Agents for Pets Sale Market Share by Application (2019-2024)
2.5.2 Global Anti-Infective Agents for Pets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Anti-Infective Agents for Pets Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Anti-Infective Agents for Pets Breakdown Data by Company
3.1.1 Global Anti-Infective Agents for Pets Annual Sales by Company (2019-2024)
3.1.2 Global Anti-Infective Agents for Pets Sales Market Share by Company (2019-2024)
3.2 Global Anti-Infective Agents for Pets Annual Revenue by Company (2019-2024)
3.2.1 Global Anti-Infective Agents for Pets Revenue by Company (2019-2024)
3.2.2 Global Anti-Infective Agents for Pets Revenue Market Share by Company (2019-2024)
3.3 Global Anti-Infective Agents for Pets Sale Price by Company
3.4 Key Manufacturers Anti-Infective Agents for Pets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infective Agents for Pets Product Location Distribution
3.4.2 Players Anti-Infective Agents for Pets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Anti-Infective Agents for Pets by Geographic Region
4.1 World Historic Anti-Infective Agents for Pets Market Size by Geographic Region (2019-2024)
4.1.1 Global Anti-Infective Agents for Pets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Anti-Infective Agents for Pets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Anti-Infective Agents for Pets Market Size by Country/Region (2019-2024)
4.2.1 Global Anti-Infective Agents for Pets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Anti-Infective Agents for Pets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-Infective Agents for Pets Sales Growth
4.4 APAC Anti-Infective Agents for Pets Sales Growth
4.5 Europe Anti-Infective Agents for Pets Sales Growth
4.6 Middle East & Africa Anti-Infective Agents for Pets Sales Growth
5 Americas
5.1 Americas Anti-Infective Agents for Pets Sales by Country
5.1.1 Americas Anti-Infective Agents for Pets Sales by Country (2019-2024)
5.1.2 Americas Anti-Infective Agents for Pets Revenue by Country (2019-2024)
5.2 Americas Anti-Infective Agents for Pets Sales by Type (2019-2024)
5.3 Americas Anti-Infective Agents for Pets Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infective Agents for Pets Sales by Region
6.1.1 APAC Anti-Infective Agents for Pets Sales by Region (2019-2024)
6.1.2 APAC Anti-Infective Agents for Pets Revenue by Region (2019-2024)
6.2 APAC Anti-Infective Agents for Pets Sales by Type (2019-2024)
6.3 APAC Anti-Infective Agents for Pets Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-Infective Agents for Pets by Country
7.1.1 Europe Anti-Infective Agents for Pets Sales by Country (2019-2024)
7.1.2 Europe Anti-Infective Agents for Pets Revenue by Country (2019-2024)
7.2 Europe Anti-Infective Agents for Pets Sales by Type (2019-2024)
7.3 Europe Anti-Infective Agents for Pets Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Infective Agents for Pets by Country
8.1.1 Middle East & Africa Anti-Infective Agents for Pets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Anti-Infective Agents for Pets Revenue by Country (2019-2024)
8.2 Middle East & Africa Anti-Infective Agents for Pets Sales by Type (2019-2024)
8.3 Middle East & Africa Anti-Infective Agents for Pets Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infective Agents for Pets
10.3 Manufacturing Process Analysis of Anti-Infective Agents for Pets
10.4 Industry Chain Structure of Anti-Infective Agents for Pets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infective Agents for Pets Distributors
11.3 Anti-Infective Agents for Pets Customer
12 World Forecast Review for Anti-Infective Agents for Pets by Geographic Region
12.1 Global Anti-Infective Agents for Pets Market Size Forecast by Region
12.1.1 Global Anti-Infective Agents for Pets Forecast by Region (2025-2030)
12.1.2 Global Anti-Infective Agents for Pets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Anti-Infective Agents for Pets Forecast by Type (2025-2030)
12.7 Global Anti-Infective Agents for Pets Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Anti-Infective Agents for Pets Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Anti-Infective Agents for Pets Product Portfolios and Specifications
13.2.3 Zoetis Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Anti-Infective Agents for Pets Product Portfolios and Specifications
13.3.3 Merck Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Anti-Infective Agents for Pets Product Portfolios and Specifications
13.4.3 Elanco Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Anti-Infective Agents for Pets Product Portfolios and Specifications
13.5.3 Bayer Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Virbac
13.6.1 Virbac Company Information
13.6.2 Virbac Anti-Infective Agents for Pets Product Portfolios and Specifications
13.6.3 Virbac Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Virbac Main Business Overview
13.6.5 Virbac Latest Developments
13.7 Ceva Sante Animale
13.7.1 Ceva Sante Animale Company Information
13.7.2 Ceva Sante Animale Anti-Infective Agents for Pets Product Portfolios and Specifications
13.7.3 Ceva Sante Animale Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Sante Animale Main Business Overview
13.7.5 Ceva Sante Animale Latest Developments
13.8 Vetoquinol
13.8.1 Vetoquinol Company Information
13.8.2 Vetoquinol Anti-Infective Agents for Pets Product Portfolios and Specifications
13.8.3 Vetoquinol Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Vetoquinol Main Business Overview
13.8.5 Vetoquinol Latest Developments
13.9 Bimeda Animal Health
13.9.1 Bimeda Animal Health Company Information
13.9.2 Bimeda Animal Health Anti-Infective Agents for Pets Product Portfolios and Specifications
13.9.3 Bimeda Animal Health Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Bimeda Animal Health Main Business Overview
13.9.5 Bimeda Animal Health Latest Developments
13.10 Chanelle
13.10.1 Chanelle Company Information
13.10.2 Chanelle Anti-Infective Agents for Pets Product Portfolios and Specifications
13.10.3 Chanelle Anti-Infective Agents for Pets Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Chanelle Main Business Overview
13.10.5 Chanelle Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂